{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:28:08Z","timestamp":1794079688319,"version":"4.8.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neurot.2024.e00325","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T14:00:41Z","timestamp":1706623241000},"page":"e00325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Biomarkers of mitochondrial disorders"],"prefix":"10.1016","volume":"21","author":[{"given":"Brian J.","family":"Shayota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2024.e00325_bib1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1152\/ajpregu.00203.2017","article-title":"Comparative NMR and NIRS analysis of oxygen-dependent metabolism in exercising finger flexor muscles","volume":"313","author":"Bendahan","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.neurot.2024.e00325_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","article-title":"The science and translation of lactate shuttle theory","author":"Brooks","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.neurot.2024.e00325_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1113\/JP278930","article-title":"Mitochondrial lactate metabolism: history and implications for exercise and disease","volume":"599","author":"Glancy","year":"2021","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.neurot.2024.e00325_bib4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.mayocp.2013.06.012","article-title":"Etiology and therapeutic approach to elevated lactate levels","author":"Andersen","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"10.1016\/j.neurot.2024.e00325_bib5","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1212\/WNL.0b013e31823a0c7f","article-title":"Natural history of MELAS associated with mitochondrialDNA m.3243A>G genotype","volume":"77","author":"Kaufmann","year":"2011","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00325_bib6","first-page":"13411","article-title":"Clinical features of MELAS and its relation with A3243G gene point mutation [Internet]","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.neurot.2024.e00325_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4103\/0366-6999.187845","article-title":"Clinical and molecular characteristics in 100 Chinese pediatric patients with m.3243a>G mutation in mitochondrial DNA","volume":"129","author":"Xia","year":"2016","journal-title":"Chin Med J"},{"key":"10.1016\/j.neurot.2024.e00325_bib8","doi-asserted-by":"crossref","first-page":"41639","DOI":"10.1038\/srep41639","article-title":"Identification of miRNA, lncRNA and mRNA-associated ceRNA networks and potential biomarker for MELAS with mitochondrial DNA A3243G mutation","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2024.e00325_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ymgme.2021.11.012","article-title":"Molecular biomarkers correlate with brain grey and white matter changes in patients with mitochondrial m.3243A > G mutation","volume":"135","author":"Evangelisti","year":"2022","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.neurot.2024.e00325_bib10","first-page":"3238","article-title":"Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome","volume":"269","author":"Guerrero-Molina","year":"2022","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.neurot.2024.e00325_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejpn.2010.10.001","article-title":"Elevated CSF-lactate is a reliable marker of mitochondrial disorders in children even after brief seizures","volume":"15","author":"Magner","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.neurot.2024.e00325_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.braindev.2011.08.004","article-title":"Diagnostic accuracy of blood and CSF lactate in identifying children with mitochondrial diseases affecting the central nervous system","volume":"34","author":"Yamada","year":"2012","journal-title":"Brain Dev"},{"key":"10.1016\/j.neurot.2024.e00325_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.mito.2018.07.002","article-title":"Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients","volume":"46","author":"Sofou","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neurot.2024.e00325_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00330-016-4454-8","article-title":"Diagnostic value of MRS-quantified brain tissue lactate level in identifying children with mitochondrial disorders","volume":"27","author":"Lunsing","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.neurot.2024.e00325_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-9-52","article-title":"A\u00a0multicenter study on Leigh syndrome: disease course and predictors of survival","volume":"9","author":"Sofou","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.neurot.2024.e00325_bib16","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.4103\/0366-6999.245265","article-title":"Clinical, neuroimaging, and pathological analyses of 13 Chinese leigh syndrome patients with mitochondrial DNA mutations","author":"Yu","year":"2018","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00325_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41436-019-0613-z","article-title":"The natural history of infantile mitochondrial DNA depletion syndrome due to RRM2B deficiency","volume":"22","author":"Keshavan","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.neurot.2024.e00325_bib18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1152\/ajpregu.00001.2011","article-title":"Exertional dyspnea in mitochondrial myopathy: clinical features and physiological mechanisms","volume":"301","author":"Heinicke","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.neurot.2024.e00325_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.nmd.2013.05.007","article-title":"Lactate metabolism during exercise in patients with mitochondrial myopathy","volume":"23","author":"Jeppesen","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurot.2024.e00325_bib20","doi-asserted-by":"crossref","first-page":"835570","DOI":"10.3389\/fendo.2022.835570","article-title":"The role of lactate exercise test and fasting plasma C-peptide levels in the diagnosis of mitochondrial diabetes: analysis of clinical characteristics of 12 patients with mitochondrial diabetes in a single center with long-term follow-up","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.neurot.2024.e00325_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2007.11.018","article-title":"The in-depth evaluation of suspected mitochondrial disease","volume":"94","author":"Haas","year":"2008","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.neurot.2024.e00325_bib22","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.24506","article-title":"Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders","volume":"78","author":"Yatsuga","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2024.e00325_bib23","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1212\/01.wnl.0000436068.43384.ef","article-title":"Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease","volume":"81","author":"Davis","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2024.e00325_bib24","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1373\/clinchem.2006.081166","article-title":"Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis","volume":"53","author":"Debray","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.neurot.2024.e00325_bib25","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","article-title":"FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study","volume":"10","author":"Suomalainen","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurot.2024.e00325_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mito.2019.02.001","article-title":"Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease","volume":"48","author":"Koga","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neurot.2024.e00325_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ymgme.2013.07.011","article-title":"Mitochondrial respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites","volume":"110","author":"Clarke","year":"2013","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.neurot.2024.e00325_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbadis.2005.09.004","article-title":"Mitochondrial creatine kinase in human health and disease","author":"Schlattner","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neurot.2024.e00325_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mehy.2018.02.022","article-title":"Plasma creatine as a marker of mitochondrial dysfunction","author":"Ostojic","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.neurot.2024.e00325_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ymgme.2012.11.283","article-title":"Role of creatine as biomarker of mitochondrial diseases","volume":"108","author":"Pajares","year":"2013","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.neurot.2024.e00325_bib31","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00109-020-01967-y","article-title":"Expanding and validating the biomarkers for mitochondrial diseases","volume":"98","author":"Maresca","year":"2020","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.neurot.2024.e00325_bib32","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1073\/pnas.0906039107","article-title":"A\u00a0plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells","volume":"107","author":"Shaham","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00325_bib33","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/01.wnl.0000244435.27645.54","article-title":"Mitochondrial disease criteria Diagnostic applications in children","volume":"67","author":"Morava","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00325_bib34","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.WNL.0000031795.91814.D8","article-title":"Mitochondrial disorders A proposal for consensus diagnostic criteria in infants and children","volume":"59","author":"Wolf","year":"2002","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00325_bib35","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1023\/B:BOLI.0000043017.90837.93","article-title":"Severe lactic acidosis and acute thiamin defciency: a report of 11 neonates with unsupplemented total parenteral nutrition","volume":"27","author":"Thauvin-Robinet","year":"2004","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00325_bib36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/ajem.2000.3981","article-title":"Hyperlactatemia and hyperammonemia as secondary effects of valproic acid poisoning","volume":"18","author":"Thabet","year":"2000","journal-title":"Am J Emerg Med."},{"issue":"11","key":"10.1016\/j.neurot.2024.e00325_bib37","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/01.wnl.0000220197.36849.1e","article-title":"Endothelial dysfunction in MELAS improved by l-arginine supplementation","volume":"66","author":"Koga","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2024.e00325_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2004.11.026","article-title":"Hypocitrullinemia in patients with MELAS: an insight into the \u201cMELAS paradox\u201d","volume":"229-230","author":"Naini","year":"2005","journal-title":"J\u00a0Neurol Sci"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00325_bib39","article-title":"Arginine for the treatment of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes: a systematic review","volume":"14","author":"Argudo","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00325_bib40","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/ajmg.a.63159","article-title":"MT-ATP6 mitochondrial disease identified by newborn screening reveals a distinct biochemical phenotype","volume":"191","author":"Tise","year":"2023","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.neurot.2024.e00325_bib41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.pediatrneurol.2014.08.009","article-title":"Role of plasma amino acids and urinary organic acids in diagnosis of mitochondrial diseases in children","volume":"51","author":"Shatla","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.neurot.2024.e00325_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ymgme.2016.01.010","article-title":"Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation","volume":"117","author":"El-Hattab","year":"2016","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.neurot.2024.e00325_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ymgme.2012.01.016","article-title":"Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation","volume":"105","author":"El-Hattab","year":"2012","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.neurot.2024.e00325_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/00365513.2011.646299","article-title":"Plasma thiol status is altered in children with mitochondrial diseases","volume":"72","author":"Salmi","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.neurot.2024.e00325_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-005-4160-1","article-title":"Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment","volume":"28","author":"Hargreaves","year":"2005","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00325_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0022-510X(91)90118-Q","article-title":"Biological markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia","volume":"105","author":"Piccolo","year":"1991","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.neurot.2024.e00325_bib47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ymgme.2013.03.011","article-title":"Glutathione: a redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies","volume":"109","author":"Pastore","year":"2013","journal-title":"Mol Genet Metabol"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00325_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100001","article-title":"Degree of glutathione deficiency and redox imbalance depend on subtype of mitochondrial disease and clinical status","volume":"9","author":"Enns","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2024.e00325_bib49","article-title":"Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation","volume":"8(3):72","author":"Ito","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.neurot.2024.e00325_bib50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.mito.2021.08.011","article-title":"Serum fibroblast growth factor 21 and growth differentiation factor 15: two sensitive biomarkers in the diagnosis of mitochondrial disorders","volume":"60","author":"Huddar","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neurot.2024.e00325_bib51","doi-asserted-by":"crossref","first-page":"837575","DOI":"10.3389\/fragi.2022.837575","article-title":"Growth differentiation factor-15 in immunity and aging","volume":"3","author":"Pence","year":"2022","journal-title":"Front Aging"},{"key":"10.1016\/j.neurot.2024.e00325_bib52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jimd.12307","article-title":"Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease","volume":"44","author":"Lehtonen","year":"2021","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.neurot.2024.e00325_bib53","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Tacer","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.neurot.2024.e00325_bib54","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.neurot.2024.e00325_bib55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/cen.12095","article-title":"Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives","author":"Woo","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.neurot.2024.e00325_bib56","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast\u00a0growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurot.2024.e00325_bib57","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00325_bib58","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.3390\/ijms22126396","article-title":"Plasma gelsolin reinforces the diagnostic value of FGF-21 and GDF-15 for mitochondrial disorders","volume":"22","author":"Pe\u00f1as","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2024.e00325_bib59","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/hmg\/ddx144","article-title":"Respiratory chain enzyme deficiency induces mitochondrial location of actin-binding gelsolin to modulate the oligomerization of VDAC complexes and cell survival","volume":"26","author":"Gar\u0107\u0131a-Bartolom\u00e9","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00325_bib60","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3390\/cells9091922","article-title":"Altered expression ratio of actin-binding gelsolin isoforms is a novel hallmark of mitochondrial OXPHOS dysfunction","volume":"9","author":"Garc\u00eda-Bartolom\u00e9","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2024.e00325_bib61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurot.2024.e00325_bib62","doi-asserted-by":"crossref","first-page":"36791","DOI":"10.1038\/srep36791","article-title":"Serum neurofilament light protein predicts clinical outcome in traumatic brain injury","volume":"6","author":"Shahim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2024.e00325_bib63","doi-asserted-by":"crossref","first-page":"1011819","DOI":"10.3389\/fmed.2022.1011819","article-title":"Biomarkers of mitochondrial dysfunction in acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"9","author":"McClintock","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.neurot.2024.e00325_bib64","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3389\/fgene.2020.00844","article-title":"Circulating cell-free nucleic acids as epigenetic biomarkers in precision medicine","volume":"11","author":"Rahat","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.neurot.2024.e00325_bib65","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/clinchem\/hvab091","article-title":"Circulating cell-free mitochondrial DNA in cerebrospinal fluid as a biomarker for mitochondrial diseases","volume":"67","author":"Trifunov","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.neurot.2024.e00325_bib66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/CS20110199","article-title":"Endothelial dysfunction and increased oxidative stress in mitochondrial diseases","volume":"122","author":"Minuz","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.neurot.2024.e00325_bib67","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpeds.2016.12.031","article-title":"Lactate and lactate: pyruvate ratio in the diagnosis and outcomes of pediatric acute liver failure","volume":"182","author":"Feldman","year":"2017","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00325_bib68","first-page":"80","article-title":"Use of FGF-21 as a biomarker of mitochondrial disease in clinical practice","volume":"6","author":"Morovat","year":"2017","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.neurot.2024.e00325_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pediatrneurol.2022.04.013","article-title":"Phenotype-genotype analysis based on molecular classification in 135 children with mitochondrial disease","volume":"132","author":"Wu","year":"2022","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.neurot.2024.e00325_bib70","first-page":"556","article-title":"Muscle computed tomography patterns in patients with the mitochondrial DNA mutation 3243A>G","volume":"251","author":"K\u00e4rpp\u00e4","year":"2004","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.neurot.2024.e00325_bib71","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ajmg.a.36939","article-title":"Biochemical abnormalities in Pearson syndrome","volume":"167","author":"Crippa","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.neurot.2024.e00325_bib72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2164-15-91","article-title":"Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies","volume":"15","author":"Kalko","year":"2014","journal-title":"BMC Genom"},{"key":"10.1016\/j.neurot.2024.e00325_bib73","first-page":"69","article-title":"Serum GDF15 levels correlate to mitochondrial disease severity and myocardial strain, but not to disease progression in adult m.3243A>G carriers","volume":"24","author":"Koene","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.neurot.2024.e00325_bib74","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.0000000000002705","article-title":"A\u00a0comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases","volume":"86","author":"Davis","year":"2016","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.neurot.2024.e00325_bib75","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1212\/WNL.0000000000003374","article-title":"FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders","volume":"87","author":"Lehtonen","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00325_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148709","article-title":"GDF-15 is elevated in children with mitochondrial diseases and is induced by mitochondrial dysfunction","volume":"11","author":"Montero","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2024.e00325_bib77","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1007\/s12035-016-0283-7","article-title":"Growth differentiation factor 15 is a novel diagnostic biomarker of mitochondrial diseases","volume":"54","author":"Ji","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2024.e00325_bib78","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jimd.12142","article-title":"Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders","volume":"42","author":"Tsygankova","year":"2019","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.neurot.2024.e00325_bib79","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1007\/s10072-020-04422-5","article-title":"Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions","volume":"41","author":"Formichi","year":"2020","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00325_bib80","doi-asserted-by":"crossref","first-page":"fcaa222","DOI":"10.1093\/braincomms\/fcaa222","article-title":"Serum biomarkers in primary mitochondrial disorders","volume":"3","author":"Varhaug","year":"2021","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurot.2024.e00325_bib81","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cca.2012.09.019","article-title":"FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease","volume":"414","author":"Su","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.neurot.2024.e00325_bib82","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1007\/s11033-013-2767-0","article-title":"Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia)","volume":"40","author":"Salehi","year":"2013","journal-title":"Mol Biol Rep"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00325_bib83","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000000578","article-title":"Serum FGF21 levels in adult m.3243A.G carriers: clinical implications","volume":"83","author":"Koene","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00325_bib84","first-page":"31","article-title":"The relationship between mitochondrial respiratory chain activities in muscle and metabolites in plasma and urine: a retrospective study","volume":"6","author":"Alban","year":"2017","journal-title":"J\u00a0Clin Med"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:15:04Z","timestamp":1761808504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1878747924000114"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00325","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of mitochondrial disorders","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00325"}}